Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Innate Pharma SA reports today its financial results for 2008: stable operational expenses and expanded R&D portfolio.
| Download Area |
|---|
| PR in english |
| CP en français |
| Slideshow in english |